Tecan Collaborates with Arizona State University to Rapidly Assess Radiation Exposure
News May 04, 2010
Tecan is collaborating with Arizona State University (ASU) to develop the Integrated Biodosimetry System, a prototype robotic system for high throughput screening to measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident.
The project, involving several prestigious organizations, is supported by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA), and focuses on development of a system to enable triage of patients than is currently possible. Tecan, the ASU Biodesign Institute and its partners hope to demonstrate proof-of-concept of the platform technology by the end of the current contract period.
Dr Carl Yamashiro, principal investigator at ASU’s Biodesign Institute, explained: “The research team will work with Tecan on building a comprehensive high throughput system, allowing scientists to analyze blood samples from up to 2,000 people per day, per instrument. The beauty of our system is its versatility. Not only will we be developing a system for the effective response to a nuclear or radiological event that could affect a large population, but the high throughout platform can also be used to advance genomics testing and other routine laboratory procedures that measure gene expression levels.”
Peter Siesel, Vice President of Sales and Marketing at Tecan, said: “We are pleased and excited to be part of this impressive collaboration. Tecan has a long history of providing world-class automation solutions for our partners and customers. This project is especially important because of its significance to the defense and protection of the US population.”
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018